Sleep deficits in the high arctic summer in relation to light exposure and behaviour: Use of melatonin as a countermeasure

Sleep Medicine

Volumn 16, Issue 3, 2015, Pages 406-413

  Paul, Michel A ^a   Love, Ryan J ^a   Hawton, Andrea ^a   Brett, Kaighley ^b,c   McCreary, Donald R ^a   Arendt, Josephine ^d  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^b Station Ftn Forces   (Canada)

^c Canadian Forces Station Alert   (Canada)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Circadian rhythms; Dim light melatonin onset; Fatigue; Polar regions

Indexed keywords

MELATONIN; CENTRAL DEPRESSANT AGENT;

ACTIMETRY; ADULT; ARTICLE; CANADA; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIM LIGHT MELATONIN ONSET; FATIGUE; FEMALE; HORMONE DETERMINATION; HUMAN; LIGHT EXPOSURE; MALE; MIDDLE AGED; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; SALIVA ANALYSIS; SLEEP; SLEEP DISORDER; SLEEP EFFICIENCY; SLEEP PARAMETERS; SLEEP PATTERN; SLEEP QUALITY; SLEEP QUANTITY; SLEEP TIME; SLEEP WAKING CYCLE; SUMMER; YOUNG ADULT; ARCTIC; CLINICAL TRIAL; METABOLISM; SEASON; SLEEP DISORDERS, CIRCADIAN RHYTHM; SUNLIGHT; TIME;

ACTIGRAPHY; ADULT; ARCTIC REGIONS; CANADA; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; SEASONS; SLEEP DISORDERS, CIRCADIAN RHYTHM; SUNLIGHT; TIME FACTORS; YOUNG ADULT;

EID: 84925273325     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.12.012     Document Type: Article

References (35)

1. Zeitzer J.M., Dijk D.J., Kronauer R.E., Brown E.N., Czeisler C.A. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000, 526:695-702.
2. Duffy J.F., Wright K.P. Entrainment of the human circadian system by light. J Biol Rhythms 2005, 20:326-338.
3. Van Den Heuvel C.J., Lushington K. Chronobiology and insomnia: pathophysiology and treatment of circadian rhythm sleep disorders. Expert Rev Neurother 2002, 2:249-260.
4. Paul M.A., Love R.J., Hawton A., Arendt J. Sleep and the endogenous melatonin rhythm of high arctic residents during the summer and winter. Physiol Behav 2015, 141:199-206.
5. Paul M.A., Love R.J., Hawton A.M., et al. Melatonin production, sleep patterns and modeled performance effectiveness in subjects in the high Arctic 2014, DRDC-RDDC-2014-R15, DRDC Toronto Research Centre.
6. Minors D.S., Waterhouse J.M., Wirzjustice A.A. Human phase response curve to light. Neurosci Lett 1991, 133:36-40.
7. Lewy A.J., Bauer V.K., Ahmed S., et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 1998, 15:71-83.
8. Khalsa S.B., Jewett M.E., Cajochen C., Czeisler C.A. A phase response curve to single bright light pulses in human subjects. J Physiol 2003, 549:945-952.
9. Paul M.A., Miller J.C., Love R.J., Lieberman H.R., Blazeski S., Arendt J. Timing light treatment for eastward and westward travel preparation. Chronobiol Int 2009, 26:867-890.
10. Deacon S.J., Arendt J. Phase-shifts in melatonin, 6-sulphatoxymelatonin and alertness rhythms after treatment with moderately bright light at night. Clin Endocrinol (Oxf) 1994, 40:413-420.
11. Shibui K., Uchiyama M., Okawa M. Melatonin rhythms in delayed sleep phase syndrome. J Biol Rhythms 1999, 14:72-76.
12. Burgess H.J., Revell V.L., Molina T.A., Eastman C.I. Human phase response curves to 3 days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab 2010, 10.1210/jc.2009-2590.
13. Burgess H.J., Revell V.L., Eastman C.I. A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol 2008, 586(2):639-647.
14. Lewy A.J., Ahmed S., Jackson J.M., Sack R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992, 9:380-392.
15. Rosenthal N.E., Josephvanderpool J.R., Levendosky A.A., et al. Phase-shifting effects of bright morning light as a treatment for delayed sleep phase syndrome. Sleep 1990, 13:354-361.
16. Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., Parkes J.D. Delayed sleep phase syndrome response to melatonin. Lancet 1991, 337:1121-1124.
17. Revell V.L., Burgess H.J., Gazda C.J., Smith M.R., Fogg L.F., Eastman C.I. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. J Clin Endocrinol Metab 2006, 91:54-59.
18. Smith M.R., Revell V.L., Eastman C.I. Phase advancing the human circadian clock with blue-enriched polychromatic light. Sleep Med 2009, 10:287-294.
19. Horne J.A., Donlon J., Arendt J. Green light attenuates melatonin output and sleepiness during sleep-deprivation. Sleep 1991, 14:233-240.
20. Miyamoto Y., Sancar A. Vitamin B2-based blue-light photoreceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals. Proc Natl Acad Sci U S A 1998, 95:6097-6102.
21. Sasseville A., Paquet N., Sevigny J., Hebert M. Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J Pineal Res 2006, 41:73-78.
22. Thapan K., Arendt J., Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 2001, 535:261-267.
23. Brainard G.C., Hanifin J.P., Greeson J.M., et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001, 21:6405-6412.
24. Freedman M.S., Lucas R.J., Soni B., et al. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:502-504.
25. Hattar S., Liao H.W., Takao M., Berson D.M., Yau K.W. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002, 295:1065-1070.
26. Paul M.A., Miller J.C., Gray G., Buick F., Blazeski S., Arendt J. Circadian phase delay induced by phototherapeutic devices. Aviat Space Environ Med 2007, 78:645-652.
27. Paul M.A., Miller J.C., Gray G.W., Love R.J., Lieberman H.R., Arendt J. Melatonin treatment for eastward and westward travel preparation. Psychopharmacology (Berl) 2010, 208:377-387.
28. Paul M.A., Gray G.W., Lieberman H.R., et al. Phase advance with separate and combined melatonin and light treatment. Psychopharmacology (Berl) 2011, 214:515-523.
29. Cole R.J., Kripke D.F., Gruen W., Mullaney D.J., Gillin J. Automatic sleep/wake identification from wrist activity. Sleep 1992, 15:461-469.
30. de Souza L., Benedito-Silva A.A., Pires M.L.N., Poyares D., Tufik S., Calil H.M. Further validation of actigraphy for sleep studies. Sleep 2003, 26:81-85.
31. Ancoli-Israel S., Cole R., Alessi C., Chambers M., Moorcroft W., Pollak C.P. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26:342-392.
32. Paul M.A., Gray G., Sardana T.M., Pigeau R.A. Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews. Aviat Space Environ Med 2004, 75:439-443.
33. Paul M.A., Gray G., MacLellan M., Pigeau R.A. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. Aviat Space Environ Med 2004, 75:512-519.
34. Paul M.A., Gray G., Kenny G., Pigeau R. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003, 74:1263-1270.
35. Paul M.A., Brown G., Buguet A., et al. Melatonin and zopiclone as pharmacologic aids to facilitate crew rest. Aviat Space Environ Med 2001, 72:974-984.